These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 18568530

  • 1. Modern imaging of multiple myeloma.
    Seppanen M.
    Acta Radiol; 2008 Jun; 49(5):487-8. PubMed ID: 18568530
    [No Abstract] [Full Text] [Related]

  • 2. Imaging in multiple myeloma.
    Delorme S, Baur-Melnyk A.
    Eur J Radiol; 2009 Jun; 70(3):401-8. PubMed ID: 19272726
    [Abstract] [Full Text] [Related]

  • 3. Myeloma update.
    Mulligan ME.
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):231-9. PubMed ID: 18260033
    [Abstract] [Full Text] [Related]

  • 4. F-18 FDG PET/CT staging of multiple myeloma with diffuse osseous and extramedullary lesions.
    Wiesenthal AA, Nguyen BD.
    Clin Nucl Med; 2007 Oct; 32(10):797-801. PubMed ID: 17885362
    [Abstract] [Full Text] [Related]

  • 5. Imaging patients with myeloma.
    Winterbottom AP, Shaw AS.
    Clin Radiol; 2009 Jan; 64(1):1-11. PubMed ID: 19070692
    [Abstract] [Full Text] [Related]

  • 6. Comparison of magnetic resonance imaging-fluorodeoxyglucose positron emission tomography fusion with pathological staging in rectal cancer (Br J Surg 2010; 97: 266-268).
    Talapatra K, Mallick S.
    Br J Surg; 2010 Jul; 97(7):1151; author reply 1151. PubMed ID: 20632294
    [No Abstract] [Full Text] [Related]

  • 7. Marginal zone lymphoma involving subcutaneous fat: appearance by FDG-PET/CT, MRI, and contrast-enhanced CT imaging.
    Chong EA, Torigian DA, Mato AR, Downs LH, Schuster SJ.
    Clin Nucl Med; 2008 Oct; 33(10):692-3. PubMed ID: 18806570
    [No Abstract] [Full Text] [Related]

  • 8. Fluorine-18-deoxyglucose-positron emission tomography imaging with magnetic resonance and computed tomographic correlation in the evaluation of bone and soft-tissue sarcomas: a pictorial essay.
    Tewfik JN, Greene GS.
    Curr Probl Diagn Radiol; 2008 Oct; 37(4):178-88. PubMed ID: 18502325
    [Abstract] [Full Text] [Related]

  • 9. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG.
    Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
    [Abstract] [Full Text] [Related]

  • 10. Hematopoietic tumors and metastases involving bone.
    Kim SH, Smith SE, Mulligan ME.
    Radiol Clin North Am; 2011 Nov; 49(6):1163-83, vi. PubMed ID: 22024293
    [Abstract] [Full Text] [Related]

  • 11. Abdominal manifestations of extraosseous myeloma: cross-sectional imaging spectrum.
    Philips S, Menias C, Vikram R, Sunnapwar A, Prasad SR.
    J Comput Assist Tomogr; 2012 Nov; 36(2):207-12. PubMed ID: 22446361
    [Abstract] [Full Text] [Related]

  • 12. Update on diagnostic imaging for melanoma.
    Grasee EA, Wagner JD.
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):49-60. PubMed ID: 15062287
    [No Abstract] [Full Text] [Related]

  • 13. Retroperitoneal plasmacytoma.
    Safar B, Thupili C, Gandhi N.
    J Urol; 2013 Jul; 190(1):280-1. PubMed ID: 23602634
    [No Abstract] [Full Text] [Related]

  • 14. [Diagnosis and follow-up with 18F-fluorodeoxiglucose positron emission tomography/computed tomography of extraosseous myeloma].
    Garcia JR, Canales M, Ponce A, Buxeda M, Moragas M, Soler M.
    Rev Esp Med Nucl Imagen Mol; 2014 Jul; 33(2):115-7. PubMed ID: 23867637
    [No Abstract] [Full Text] [Related]

  • 15. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
    Pace L, Salvatore M, Del Vecchio S.
    J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
    [No Abstract] [Full Text] [Related]

  • 16. Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
    Goerres GW, Schuknecht B, Schmid DT, Stoeckli SJ, Hany TF.
    Clin Imaging; 2008 Mar; 32(6):431-7. PubMed ID: 19006770
    [Abstract] [Full Text] [Related]

  • 17. Multiple myeloma.
    Peller PJ.
    PET Clin; 2015 Apr; 10(2):227-41. PubMed ID: 25829088
    [Abstract] [Full Text] [Related]

  • 18. (18)F-Fluorodeoxyglucose avid liver lesion in a patient with multiple myeloma.
    Matsue K, Odawara J, Kimura S, Yamakura M, Takeuchi M.
    Eur J Haematol; 2009 Aug; 83(2):163-4. PubMed ID: 19226413
    [No Abstract] [Full Text] [Related]

  • 19. Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma.
    Zamagni E, Nanni C, Tacchetti P, Pantani L, Marzocchi G, Zannetti B, Terragna C, Mancuso K, Rocchi S, Pezzi A, Testoni N, Fanti S, Cavo M.
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e101-4. PubMed ID: 24508412
    [No Abstract] [Full Text] [Related]

  • 20. Multiple myeloma presenting with [18F]fluorodeoxyglucose avid liver lesions diagnosed on positron emission tomography scan.
    Ghesani M, Goel S, Cohen S, Maslin P, Meka M, Chang A.
    J Clin Oncol; 2007 Nov 20; 25(33):5319-20. PubMed ID: 18024877
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.